Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PRE | US
2.73
18.12%
Healthcare
Diagnostics & Research
30/06/2024
06/03/2026
17.80
16.50
18.30
16.09
Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA a consumer genetic testing product; and Circle HealthPod a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use. The company's products also comprise ColoClear a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot an off-the-shelf at-home blood test; ACTOnco a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+ a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra a genomic profiling service for solid tumors. It also offers ACTMonitor a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay Hong Kong.
View LessStrength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
131.7%1 month
110.3%3 months
89.3%6 months
100.1%-
-
0.33
0.01
0.01
0.14
0.55
-
-36.70M
217.47M
217.47M
-
-178.56
-
4.30
-21.67
1.94
0.32
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
4.71
Range1M
8.31
Range3M
9.24
Rel. volume
1.26
Price X volume
7.32M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| MDxHealth SA | MDXH | Diagnostics & Research | 3.27 | 154.63M | -1.21% | n/a | -643.01% |
| Common Stock | PROF | Diagnostics & Research | 5.31 | 130.51M | -29.11% | n/a | 0.00% |
| Common Stock | BNGO | Diagnostics & Research | 1.12 | 96.32M | -0.88% | 0.03 | 34.32% |
| Anixa Biosciences Inc | ANIX | Diagnostics & Research | 2.85 | 91.71M | -1.38% | n/a | 1.09% |
| Co-Diagnostics Inc | CODX | Diagnostics & Research | 2.11 | 67.33M | -9.44% | n/a | 3.57% |
| Sera Prognostics Inc. | SERA | Diagnostics & Research | 1.95 | 65.07M | -2.50% | n/a | 2.27% |
| ENDRA Life Sciences Inc | NDRA | Diagnostics & Research | 3.36 | 61.79M | -2.04% | n/a | 3.13% |
| Cytosorbents Corporation | CTSO | Diagnostics & Research | 0.798 | 43.43M | -0.88% | n/a | 159.92% |
| Neuronetics Inc | STIM | Diagnostics & Research | 1.38 | 41.82M | -2.13% | n/a | 323.03% |
| Precipio Inc | PRPO | Diagnostics & Research | 26.5342 | 39.33M | 0.05% | n/a | 9.66% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CPI Card Group Inc | PMTS | Building Products & Equipment | 15.52 | 173.17M | -11.82% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 9.86 | 158.32M | -6.01% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 41.85 | 120.19M | 2.07% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.25 | 101.81M | -0.95% | 9.09 | 39.79% |
| Reading International Inc | RDIB | Media - Diversified | 11.55 | 90.60M | -5.17% | n/a | 4054.78% |
| ILAG | ILAG | Building Products & Equipment | 2.4783 | 44.76M | 6.82% | n/a | 5.48% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.21 | 32.29M | -3.49% | 0.03 | 16.03% |
| Reading International Inc | RDI | Media - Diversified | 0.9993 | 28.21M | -2.98% | n/a | 4054.78% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.6345 | 12.26M | -10.63% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.4799 | 3.78M | -0.68% | n/a | 17.32% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.14 | 12.67 | Cheaper |
| Ent. to Revenue | 0.55 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 0.33 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 89.25 | 59.59 | Riskier |
| Debt to Equity | 0.01 | -14.36 | Expensive |
| Debt to Assets | 0.01 | 0.34 | Cheaper |
| Market Cap | 217.47M | 13.71B | Emerging |